Dr. Allen S. Lichter And Ruediger Naumann-Etienne Elected To Varian Medical Systems’ Board Of Directors | Varian

Dr. Allen S. Lichter And Ruediger Naumann-Etienne Elected To Varian Medical Systems’ Board Of Directors

Palo Alto, Calif. - February 14, 2003 - Varian Medical Systems, Inc. (NYSE:VAR)today announced that Dr. Allen S. Lichter, M.D., and Ruediger Naumann-Etienne,
PhD, have been elected to its board of directors.  The two new board
members are replacing Richard W. Vieser and Burton Richter, PhD, who have
retired from the seven-member body.  Richard M. Levy, PhD, president and
CEO of Varian Medical Systems, has replaced Vieser as chairman of the board
following his election to that position in December.  Board member Dr.
David Martin, M.D., has been re-elected to serve an additional three-year
term.

"We have made two excellent additions to our board to replace two board
members who have been of superb service to Varian over the years," said
Levy.  "Allen Lichter brings deep knowledge of oncology as well as the
economic, social, and educational issues influencing the U.S. healthcare
system.  Ruediger Naumann-Etienne combines expertise in finance with a
wealth of experience in the management and stewardship of medical technology
enterprises.  Their leadership will be of great value as we continue to
develop the Varian Medical Systems business."

Dr. Allen Lichter

Dr. Lichter is Dean of the University of Michigan Medical School and Newman
Family Professor of Radiation Oncology.  He sits on the Board of
Directors of the Accreditation Council for Graduate Medical Education
(ACGME).  He received his B.S. from the University of Michigan in 1968
and his M.D. from the University of Michigan Medical School in 1972.  He
is a past president of the American Society of Clinical Oncology and he has
served on the Board of Directors of the American Society for Therapeutic
Radiology and Oncology.  He was also Director of the Radiation Therapy
Section of the National Cancer Institute's Radiation Oncology Branch.

At the University of Michigan Comprehensive Cancer Center, Dr. Lichter served
as Director of the Breast Oncology Program where he conducted internationally
recognized research that led to new treatment standards emphasizing breast
preservation by combining radiation therapy with a lumpectomy.

Ruediger Naumann-Etienne

Naumann-Etienne is the owner and Managing Director of Intertec Group, an
investment company specializing in medical technology.  He holds a PhD in
International Finance from the University of Michigan, a Master's Degree in
Industrial Management from the Georgia Institute of Technology, and he
completed undergraduate work in Business Administration at the Technical
University Berlin in Germany.

Naumann-Etienne currently is Chairman of the Board and CEO of Quinton
Cardiology Systems (NASDAQ:QUIN) in Bothell, WA.  He also is a director
for Bio-Rad Laboratories (ASE:BIO) in Hercules, CA, and The Exploratorium
science museum in San Francisco. 

He served as CEO and Chairman of the Board of OEC Medical Systems in Salt Lake
City until General Electric acquired it in November of 1999.  Earlier, he
served as President, Chief Operating Officer, and Chief Financial Officer of
Diasonics in Milpitas.  He also worked for Hambrecht and Quist in San
Francisco and he held various management positions at Texas Instruments in
Dallas, including Group Controller.

Varian Medical Systems, Inc., (NYSE:VAR) of Palo Alto, California is the
world's leading manufacturer of integrated cancer therapy systems, which are
treating thousands of patients per day.  The company is also a premier
supplier of X-ray tubes and flat-panel digital subsystems for imaging in
medical, scientific, and industrial applications.  Varian Medical Systems
employs approximately 2,750 people who are located at manufacturing sites in
North America and Europe and in its 50 sales and support offices around the
world.  In its most recent fiscal year ended September 27, 2002, Varian
Medical Systems reported sales of $873 million.  Additional information
is available on the company's investor relations web site at www.varian.com.